These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
209 related articles for article (PubMed ID: 18285408)
1. Increased androgen response to follicle-stimulating hormone administration in women with polycystic ovary syndrome. Wachs DS; Coffler MS; Malcom PJ; Shimasaki S; Chang RJ J Clin Endocrinol Metab; 2008 May; 93(5):1827-33. PubMed ID: 18285408 [TBL] [Abstract][Full Text] [Related]
2. Comparison of follicle-stimulating-hormone-stimulated dimeric inhibin and estradiol responses as indicators of granulosa cell function in polycystic ovary syndrome and normal women. Wachs DS; Coffler MS; Malcom PJ; Chang RJ J Clin Endocrinol Metab; 2006 Aug; 91(8):2920-5. PubMed ID: 16720653 [TBL] [Abstract][Full Text] [Related]
3. Relationship between 17-hydroxyprogesterone responses to human chorionic gonadotropin and markers of ovarian follicle morphology in women with polycystic ovary syndrome. Maas KH; Chuan SS; Cook-Andersen H; Su HI; Duleba A; Chang RJ J Clin Endocrinol Metab; 2015 Jan; 100(1):293-300. PubMed ID: 25313914 [TBL] [Abstract][Full Text] [Related]
4. The effect of androgen blockade on granulosa cell estradiol production after follicle-stimulating hormone stimulation in women with polycystic ovary syndrome. Mehta RV; Malcom PJ; Chang RJ J Clin Endocrinol Metab; 2006 Sep; 91(9):3503-6. PubMed ID: 16804036 [TBL] [Abstract][Full Text] [Related]
5. Ovarian age-related responsiveness to human chorionic gonadotropin in women with polycystic ovary syndrome. Piltonen T; Koivunen R; Perheentupa A; Morin-Papunen L; Ruokonen A; Tapanainen JS J Clin Endocrinol Metab; 2004 Aug; 89(8):3769-75. PubMed ID: 15292303 [TBL] [Abstract][Full Text] [Related]
6. Serum anti-mullerian hormone concentrations are not altered by acute administration of follicle stimulating hormone in polycystic ovary syndrome and normal women. Wachs DS; Coffler MS; Malcom PJ; Chang RJ J Clin Endocrinol Metab; 2007 May; 92(5):1871-4. PubMed ID: 17299061 [TBL] [Abstract][Full Text] [Related]
7. Comparison of inhibin B and estradiol responses to intravenous FSH in women with polycystic ovary syndrome and normal women. Rosencrantz MA; Wachs DS; Coffler MS; Malcom PJ; Donohue M; Chang RJ Hum Reprod; 2010 Jan; 25(1):198-203. PubMed ID: 19850592 [TBL] [Abstract][Full Text] [Related]
8. Obesity and serum luteinizing hormone level have an independent and opposite effect on the serum inhibin B level in patients with polycystic ovary syndrome. Cortet-Rudelli C; Pigny P; Decanter C; Leroy M; Maunoury-Lefebvre C; Thomas-Desrousseaux P; Dewailly D Fertil Steril; 2002 Feb; 77(2):281-7. PubMed ID: 11821084 [TBL] [Abstract][Full Text] [Related]
9. Serum levels of inhibins are differentially altered in patients with polycystic ovary syndrome: effects of being overweight and relevance to hyperandrogenism. Pigny P; Cortet-Rudelli C; Decanter C; Deroubaix D; Soudan B; Duhamel A; Dewailly D Fertil Steril; 2000 May; 73(5):972-7. PubMed ID: 10785223 [TBL] [Abstract][Full Text] [Related]
10. In-vivo ovarian androgen responses to recombinant FSH with and without recombinant LH in polycystic ovarian syndrome. Cheung AP; Pride SM; Yuen BH; Sy L Hum Reprod; 2002 Oct; 17(10):2540-7. PubMed ID: 12351525 [TBL] [Abstract][Full Text] [Related]
11. Serum anti-Müllerian hormone levels remain high until late reproductive age and decrease during metformin therapy in women with polycystic ovary syndrome. Piltonen T; Morin-Papunen L; Koivunen R; Perheentupa A; Ruokonen A; Tapanainen JS Hum Reprod; 2005 Jul; 20(7):1820-6. PubMed ID: 15802325 [TBL] [Abstract][Full Text] [Related]
12. Anti-Müllerian Hormone and Inhibin-A, but not Inhibin-B or Insulin-Like Peptide-3, may be Used as Surrogates in the Diagnosis of Polycystic Ovary Syndrome in Adolescents: Preliminary Results. Yetim A; Yetim Ç; Baş F; Erol OB; Çığ G; Uçar A; Darendeliler F J Clin Res Pediatr Endocrinol; 2016 Sep; 8(3):288-97. PubMed ID: 27125339 [TBL] [Abstract][Full Text] [Related]
13. Lack of Serum anti-Mullerian hormone responses after recombinant human chorionic gonadotropin stimulation in women with polycystic ovary syndrome. Cook-Andersen H; Chuan SS; Maas K; Rosencrantz MA; Su HI; Lawson M; Mason HD; Chang RJ J Clin Endocrinol Metab; 2015 Jan; 100(1):251-7. PubMed ID: 25303490 [TBL] [Abstract][Full Text] [Related]
14. Clinical evidence for predominance of delta-5 steroid production in women with polycystic ovary syndrome. Rosencrantz MA; Coffler MS; Haggan A; Duke KB; Donohue MC; Shayya RF; Su HI; Chang RJ J Clin Endocrinol Metab; 2011 Apr; 96(4):1106-13. PubMed ID: 21270326 [TBL] [Abstract][Full Text] [Related]
15. Pituitary-ovarian response to the gonadotrophin-releasing hormone-agonist test in anovulatory patients with polycystic ovary syndrome: predictive role of ovarian stroma. Fulghesu AM; Angioni S; Belosi C; Apa R; Selvaggi L; Ciampelli M; Iuculano A; Melis GB; Lanzone A Clin Endocrinol (Oxf); 2006 Sep; 65(3):396-401. PubMed ID: 16918963 [TBL] [Abstract][Full Text] [Related]
16. Adrenal androgenic response to 2-hour ACTH stimulation test in women with PCOS. Erel CT; Senturk LM; Oral E; Colgar U; Ertungealp E Gynecol Endocrinol; 1998 Aug; 12(4):223-9. PubMed ID: 9798131 [TBL] [Abstract][Full Text] [Related]
17. The effect of estradiol on granulosa cell responses to FSH in women with polycystic ovary syndrome. Homer MV; Rosencrantz MA; Shayya RF; Chang RJ Reprod Biol Endocrinol; 2017 Feb; 15(1):13. PubMed ID: 28187771 [TBL] [Abstract][Full Text] [Related]
18. Comparison of adrenocortical steroidogenesis in women with post-adolescent severe acne and polycystic ovary syndrome. Cinar N; Cetinozman F; Aksoy DY; Elcin G; Yildiz BO J Eur Acad Dermatol Venereol; 2015 May; 29(5):875-80. PubMed ID: 25176476 [TBL] [Abstract][Full Text] [Related]
19. Inhibin A and inhibin B in women with polycystic ovarian syndrome during treatment with FSH to induce mono-ovulation. Anderson RA; Groome NP; Baird DT Clin Endocrinol (Oxf); 1998 May; 48(5):577-84. PubMed ID: 9666869 [TBL] [Abstract][Full Text] [Related]
20. Long-term administration of gonadotropin-releasing hormone agonist and dexamethasone: assessment of the adrenal role in ovarian dysfunction. Cedars MI; Steingold KA; de Ziegler D; Lapolt PS; Chang RJ; Judd HL Fertil Steril; 1992 Mar; 57(3):495-500. PubMed ID: 1531463 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]